Liu CK

References (3)

Title : A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan - Chang_2019_Adv.Ther_36_1455
Author(s) : Chang CC , Peng GS , Lai TJ , Li CH , Liu CK
Ref : Adv Ther , 36 :1455 , 2019
Abstract : Chang_2019_Adv.Ther_36_1455
ESTHER : Chang_2019_Adv.Ther_36_1455
PubMedSearch : Chang_2019_Adv.Ther_36_1455
PubMedID: 30953330

Title : Early Statin Use and the Progression of Alzheimer Disease: A Total Population-Based Case-Control Study - Lin_2015_Medicine.(Baltimore)_94_e2143
Author(s) : Lin FC , Chuang YS , Hsieh HM , Lee TC , Chiu KF , Liu CK , Wu MT
Ref : Medicine (Baltimore) , 94 :e2143 , 2015
Abstract : Lin_2015_Medicine.(Baltimore)_94_e2143
ESTHER : Lin_2015_Medicine.(Baltimore)_94_e2143
PubMedSearch : Lin_2015_Medicine.(Baltimore)_94_e2143
PubMedID: 26632742

Title : Parallel improvement of cognitive functions and p300 latency following donepezil treatment in patients with Alzheimer's disease: a case-control study - Chang_2014_J.Clin.Neurophysiol_31_81
Author(s) : Chang YS , Chen HL , Hsu CY , Tang SH , Liu CK
Ref : J Clin Neurophysiol , 31 :81 , 2014
Abstract : Chang_2014_J.Clin.Neurophysiol_31_81
ESTHER : Chang_2014_J.Clin.Neurophysiol_31_81
PubMedSearch : Chang_2014_J.Clin.Neurophysiol_31_81
PubMedID: 24492450